NFKB1 and cancer: Several pathways have been associated with CXCR4 in cancer cells, such as Erk/p38 and PI3K/Akt/NFκB, whereas CXCR4 inhibition deactivated Akt without Erk revealing cell context-specific pathway regulation51.